In India, mental health conversations have exploded from workplaces to social media, yet 14% of the population grapples with disorders, and 70-80% lack reliable treatment. The real barrier? Not just stigma, but inconsistent access to life-sustaining medications. As Supreet Singh, Founder & CEO of Psychocare Health, argues, solving the “last-mile” supply chain gap is key to turning awareness into recovery.
In India, mental health has recently transitioned from being completely invisible to regular discussions at work, in schools, and online. There has been a significant increase in awareness through public policy campaigns and advocacy on social media.
There is an estimated 14% of the total population of India that suffers from a form of mental health disorder, yet at least 70–80% do not have adequate access to treatment. Whereas stigma was a primary access barrier, the issue of access to continuous and reliable treatment (and medication) is now of a more structural nature.
Treatment Gap Goes Beyond Therapy
Individual mental health treatment includes more than just diagnosing or providing therapy to the patient from the psychiatrist’s perspective; this principle is true for multiple types of mental illness (depression, anxiety disorders, bipolar disorder, and schizophrenia). Many require long-term treatment by means of psychoactive medication prescribed by the psychiatrist and followed up on with continued psychotherapy.
According to the World Health Organization, the greatest indicator of a patient’s potential for successful recovery from a mental disorder is their ability to successfully follow medical advice regarding taking their medication. For a medicine to yield a positive benefit, it must be taken daily for weeks or months; when patients do not follow through, their chances of recovery are limited.
Adherence is one of the major difficulties in India when managing psychiatric disorders. As noted in a recent article published by the Indian Journal of Psychiatry, nearly 50% of patients do not continue their prescribed medication after several months of starting treatment. The most prevalent reason for this discontinuation is the inability to obtain or access the required medications on a consistent basis.
The Real Bottleneck: Availability of Medicines
Although patients receive the correct drug when they are diagnosed, they do not necessarily have access to their medications.
India has a significant disparity in drug distribution due to geography. Many areas outside of major population centers have:
– Frequent stockouts for psychotropic drugs
– Limited pharmacy access for psychotropic medication
– Prescribed medication is being substituted with other drugs due to unavailability.
The report issued by the Ministry of Health and Family Welfare (India) indicates that this issue is even more prevalent in public health facilities located outside of large metropolitan areas.
Understanding the “Last-Mile” Problem
Distribution and production are both issues.
Even though India is one of the largest pharmaceutical producers in the world, at the patient level, access to these medicines remains inconsistent. This case is a classic example of the ‘last mile’ distribution dilemma; the statement that medicines exist but do not reach patients when they are needed is the truth.
Psychiatric medications are particularly sensitive to time because of the following:
• Strict dosing schedule
• Discontinuation of the drug can create withdrawal symptoms or relapse
• Treatment outcomes are directly related to the continuity of treatment over time.
According to The Lancet Commission on Global Mental Health, interruptions in treatment dramatically raise the relapse rate as well as the burden of disease from mental illnesses, especially chronic conditions.
Impact on Patients and Society
When individuals cannot consistently get their medications, it negatively affects not only their personal health but that of society as well.
The following list illustrates how much people with insufficient access to their medications suffer:
• Increased rates of relapse
• Decreased ability to carry out daily routine
• Strain on personal/professional relationships
• Increased long-term cost of healthcare for individuals and society as a whole
According to the World Economic Forum’s research, economic losses resulting from mental health conditions in India during 2012-2030 will exceed $1 trillion, most of which will stem from decreased productivity and less participation in the labor force.
Why the Supply Chain Needs Urgent Reform
An important factor is the fragmented distribution system for pharmaceuticals, particularly around neuro or psychiatric drugs.
Compared to standard medications, many neuro/psychiatric drugs:
• Have limited distribution networks
• Are kept in fewer pharmacies
• Have unreliable supply chains
Patients who want a drug can’t get it, even with a valid prescription.
Strengthening Last-Mile Access
To enhance mental health service delivery in India, it is crucial to prioritize access and continuity rather than simply raising awareness.
Some possible solutions include:
• Improving the reach of mental health services through decentralized delivery systems
• Improving forecasting of demand for inventory planning purposes
• Forming partnerships with local pharmacies and healthcare providers
• Developing a digital prescription tracking system that provides continuity of care for patients
The suggestion of the World Health Organization is to combine the mental health services and the primary health systems and to supply the appropriate psychiatric medications within the community.
Conclusion
Even though mental health has been talked about more openly in India lately, there is still little awareness amongst the general public regarding the lack of treatment options available for those suffering from mental illness.
The main focus must now be to ensure that every person who receives a diagnosis for any sort of mental illness has access to the proper medications and therapy at the time they need it.
In terms of mental health care, recovery is not only about beginning to receive treatment; it is also about remaining on treatment.
